The approval of the first oral pill this month will drive a more powerful shift in consumer habits, PwC found in a study.

Since the beginning of this decade, GLP-1 medications - which have been prescribed in Britain primarily as injections - have taken over as blockbuster drugs for weight loss.

The approval of the first oral pill this month will drive a more powerful shift in consumer habits, PwC found in a study.

The approval of the first oral pill this month will drive a more powerful shift in consumer habits